BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35648974)

  • 1. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    Trivedi HD; Lopes EW; Glissen Brown J; Dudani S; Lai M; Feuerstein JD; Pierce TT
    J Clin Gastroenterol; 2023 Jul; 57(6):610-616. PubMed ID: 35648974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis.
    Lapumnuaypol K; Kanjanahattakij N; Pisarcik D; Thongprayoon C; Wijarnpreecha K; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):854-860. PubMed ID: 29697458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
    Zou ZY; Shen B; Fan JG
    Inflamm Bowel Dis; 2019 Oct; 25(11):1764-1772. PubMed ID: 30918952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Zamani M; Alizadeh-Tabari S; Singh S; Loomba R
    Aliment Pharmacol Ther; 2022 Apr; 55(8):894-907. PubMed ID: 35274325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.
    Kodali A; Okoye C; Klein D; Mohamoud I; Olanisa OO; Parab P; Chaudhary P; Mukhtar S; Moradi A; Hamid P
    Cureus; 2023 Aug; 15(8):e42995. PubMed ID: 37671212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
    Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
    World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B
    J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Chen Y; Chen L; Xing C; Deng G; Zeng F; Xie T; Gu L; Yang H
    BMC Gastroenterol; 2020 Jun; 20(1):192. PubMed ID: 32552882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between autism spectrum disorder and inflammatory bowel disease: A systematic review and meta-analysis.
    Kim JY; Choi MJ; Ha S; Hwang J; Koyanagi A; Dragioti E; Radua J; Smith L; Jacob L; Salazar de Pablo G; Lee SW; Yon DK; Thompson T; Cortese S; Lollo G; Liang CS; Chu CS; Fusar-Poli P; Cheon KA; Shin JI; Solmi M
    Autism Res; 2022 Feb; 15(2):340-352. PubMed ID: 34939353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
    Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
    [No Abstract]   [Full Text] [Related]  

  • 11. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Carr RM; Patel A; Bownik H; Oranu A; Kerner C; Praestgaard A; Forde KA; Reddy KR; Lichtenstein GR
    Dig Dis Sci; 2017 May; 62(5):1354-1361. PubMed ID: 28265826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.
    Zhou BG; Yang HJ; Xu W; Wang K; Guo P; Ai YW
    Helicobacter; 2019 Jun; 24(3):e12576. PubMed ID: 30907050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis.
    Wu XW; Wu L; Ji HZ; Wang FY
    Dig Dis Sci; 2015 Nov; 60(11):3203-8. PubMed ID: 26031424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
    Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
    Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.
    Navarro P; Gutiérrez-Ramírez L; Tejera-Muñoz A; Arias Á; Lucendo AJ
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Noorian S; Jeon Y; Nguyen MT; Sauk J; Limketkai BN
    Inflamm Bowel Dis; 2022 Jun; 28(6):878-887. PubMed ID: 34374782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
    Zhang XY; Dong HC; Wang WF; Zhang Y
    World J Gastroenterol; 2022 Apr; 28(16):1705-1717. PubMed ID: 35581968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Lin A; Roth H; Anyane-Yeboa A; Rubin DT; Paul S
    Inflamm Bowel Dis; 2021 May; 27(6):947-955. PubMed ID: 32780094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.